Anxiolytics play a pivotal role in the management of anxiety disorders. The Journal of Clinical Psychiatry offers a comprehensive exploration of these medications, from their pharmacodynamics to their clinical applications. Our expert editors curate content that delves into the benefits, risks, and best practices associated with anxiolytic use. This ensures psychiatrists are well-informed, enabling them to make optimal therapeutic decisions for their patients.
Anxiolytics
Page 2
Recently published article about Anxiolytics
Clinical and Practical Psychopharmacology
Gestational Exposure to Benzodiazepines and Z-Hypnotics and Risk of Adverse Pregnancy Outcomes
April 3, 2023
Chittaranjan Andrade, MD, discusses recent studies on exposure to benzodiazepines and hypnotics and risk of major congenital malformation and other adverse pregnancy outcomes.
Original Research
Antipsychotics and Bacteremia in Adults With COPD
April 13, 2021
Antipsychotics may have immunomodulatory effects that could increase the risk of disseminated infections. This study sought to estimate the effect of antipsychotics on incident bloodstream infections in adults with...
Original Research
Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depression
September 29, 2020
This analysis of data from 2 clinical trials examined the effect of benzodiazepines on outcomes in older patients with generalized anxiety disorder or major depressive disorder, including the likelihood...
Article
Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis
January 29, 2019
When you treat youth with anxiety disorders, are your decisions evidence-based? This meta-analysis examined efficacy and tolerability of agents studied for pediatric anxiety in double-blind, placebo-controlled trials. Read the...
